Background and objectives: Emergence of extended spectrum beta-lactamase (ESBL) producing bacteria is a major public health concern. Detection of multi drug resistant (MDR) ESBL producing organisms is necessary to prevent its spread and effective treatment. The purpose of the present study was to determine the magnitude of ESBL producing organism in hospital setting and to compare the suitability of double disc synergy test (DDST) and cefepime-clavulanate E-test method for the detection of ESBL producing organisms in routine microbiology laboratory.
Introduction
Extended spectrum beta-lactamases are enzymes that confer resistance to the penicillin, cephalosporins and aztreonam by hydrolysis of the antibiotics. ESBL enzymes are inactivated by beta-lactamase inhibitors such as clavulanic acid [1] . Treatment of ESBL producing organisms is now a therapeutic challenge in hospitalized patients worldwide. Indiscriminate administration of extended spectrum cephalosporins, prolonged hospital stay, mechanical ventilation and catheterization are the major risk factors for colonization of ESBL producing bacteria [2] . Detection of ESBL producing organisms is necessary to prevent its spread. Several ESBL detection tests have been proposed by NCCLS [3] . The degree of resistance against extended spectrum cephalosporins can also be highly variable for the different ESBL enzymes. Thus, ESBL producing bacteria need reliable detection method [4] . Double Disc Synergy Test (DDST), is a sensitive, convenient and inexpensive method for detection of ESBL producing organisms in routine clinical laboratory service. In DDST, easily available commercial antibiotic sensitivity discs are used. Sensitivity and specificity of the method range from 79% to 97% and 94% to 100% respectively [5] . Recommendations of the Clinical and Laboratory Standards Institute (CLSI) for phenotypic confirmation of ESBL still rely on the minimum inhibitory concentration (MIC) difference test, in which a β-lactamase inhibitor is used to protect the activity of an indicator drug against an ESBL producing strain [6] . Apart from DDST, commercially available E-test is technically straight forward, versatile and easy to use method for ESBL detection and is an attractive alternative to conventional MIC dilution test. Three types of E-test strips such as cefepime-clavulanate, cefotaxime-clavulanate and ceftazidime-clavulanate in different antibiotic gradient concentrations are available for the detection of ESBL. Detection of MIC using E-test is convenient and easy to use, but it is sometime difficult to read the test when the MIC of the bacterial strain are below or above the range of antibiotics used in the strip [7] . Therefore, the result may be non-determinable if the MIC of the test organism is beyond the antibiotic range [8] . Sensitivity and specificity of E-test for detection of ESBL producers are 87% to 100% and 95% to 100% respectively [9] . Moreover, E-test strip method is expensive and gives false negative result, which may cause therapeutic failure. Except in a few microbiology laboratories, ESBL screening is not routinely practiced in Bangladesh.
Therefore, the present study was undertaken to determine the magnitude of ESBL producing organisms in tertiary hospitals and to compare the DDST with that of commercially available E-test to detect ESBL producing Gram negative organisms isolated from clinical samples.
Materials and Methods
Study population and place: This Cross-sectional study was carried out at the Department of Microbiology, Sir Salimullah Medical College, Dhaka for a period of one year from January 2011 to December 2011. A total 354 clinical samples were collected from inpatient and outpatient departments of Mitford Hospital, and Burn Unit of Dhaka Medical College Hospital in Dhaka. Samples were collected from suspected cases of urinary tract infection, burn and surgical wound infections.
Isolation and identification of organisms:
Samples were inoculated onto blood agar and MacConkey's agar media for isolation and identification of the organisms. All plates were incubated at 37 0 C aerobically for 24-48 hrs. Suspected organisms were identified by standard biochemical tests [10] .
Tests for the detection of ESBL producing organisms: All isolated organisms were tested for ESBL production by DDS test and E-test methods.
a. Double Disc Synergy Test: All isolated
Gram-negative bacteria were tested for ESBL production by DDST using aztreonam (30 µg), ceftazidime (30 µg), ceftriaxone (30 µg), cefotaxime (30 µg) and 20µg amoxicillin +10µg clavulanic acid discs. The four antibiotic discs were placed 20 mm apart from each other with amoxicillin /clavulanic acid disc at the center as shown in Fig-1a . ESBL production was considered positive when the zone of inhibition around any antibiotic disc was enhanced towards the amoxicillin/clavulanic acid disc [11] .
b. Detection of ESBL by E-test Method: E-test cefepime/cefepime+clavulanic acid (PM / PML) strip (AB Biodisk, Solna, Sweden), containing cefepime / cefepime+clavulanic acid (cefepime MIC range, 0.25-16 mg/L; Cefepime/clavulanic acid MIC range 0.064-4 mg/L plus 4 mg/L clavulanic acid) were used. E-test procedure, reading and interpretation were carried out according to the manufacturer's instructions. The presence of ESBL is confirmed by the appearance of a phantom zone or deformation of the PM ellipse (Fig-1b) (Fig 1c) . 
Discussion
In recent years, beta-lactamase producing Gramnegative bacilli have increased and become a leading cause of resistance to beta-lactam antibiotics [10] . Detection of ESBL producing strains is important for instituting effective treatment and containment of its outbreak in hospitals and healthcare facilities [12] . The present study has revealed that a large number of Gramnegative organisms were ESBL producers imparting a major threat in escalation of treatment cost and spread of these multi drug resistant organisms. ESBL producing organisms were detected with equal efficiency by both DDST and E-test methods. However, four isolates which were found as ESBL producers by DDST were nondeterminable by E-test. Probably, the MICs of those isolates to cefepime were beyond the 1a 1b 1c cefepime concentration present in the PM/PML Etest strip (cefepime MIC range 0.25-16 mg/L; Cefepime/clavulanic acid MIC range 0.064-4 mg/L plus 4 mg/L clavulanic acid) [13] . It appears that the DDST could be more sensitive in detecting potential ESBL producers as it takes into account the enhancement or potentiation of zone of inhibition against any of the four antibiotics discs namely ceftriaxone, ceftazidime, cefotaxime and aztreonam [14, 15] . However, such discrepant results should be confirmed by molecular methods or by wide range MIC test.
The study has demonstrated that a good proportion of Gram-negative organisms isolated from clinical samples were ESBL producers. Compared to expensive E-test, DDST is a reliable, convenient, relatively inexpensive and easy to perform method for detection of ESBL producing organisms in routine clinical laboratories.
